Barclays raised the firm’s price target on GSK to 1,725 GBp from 1,575 GBp and keeps an Equal Weight rating on the shares. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on GSK: CureVac announces Phase 2 interim data from influenza vaccine program GSK Updates Total Voting Rights for Shareholders GSK Executive Sells Shares on LSE GlaxoSmithKline Executes Major Share Transfer GSK caps U.S. out-of-pocket costs at $35/month for portfolio of COPD inhalers